[Parsonage-Turner syndrome following severe SARS-CoV-2 infection].

Syndrome de Parsonage-Turner compliquant une infection sévère à SARS-CoV-2.
Amyotrophie névralgique COVID-19 Dyspnea Dyspnée Neuralgic amyotrophy Paralysie diaphragmatique Parsonage Turner syndrome Respiratory diaphragmatic paralysis SARS Coronavirus SARS-Cov-2 Syndrome de Parsonage-Turner

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 13 01 2021
accepted: 01 06 2021
pubmed: 31 7 2021
medline: 14 10 2021
entrez: 30 7 2021
Statut: ppublish

Résumé

Complications following COVID-19 are starting to emerge; neurological disorders are already described in the literature. This case is about a 20-year old male with a severe COVID-19, hospitalized in a Reanimation and Intensive Care Unit with an Acute Respiratory Distress Syndrome, thromboembolic complication and secondary bacterial infection. This patient had a non-specific neurological disorder with a pseudobulbar palsy, (MRI, ENMG and lumbar puncture were normal), associated 4 months later with persistent left shoulder motor deficit and respiratory failure. Respiratory and neurological check-up led to a diagnosis of the Parsonage-Turner syndrome or neuralgic amyotrophy affecting C5-C6 nerve roots, the lateral pectoral and phrenic nerves at the origin of the scapular belt, amyotrophy and left diaphragm paralysis. This case shows that persistant dyspnoea after COVID 19 infection should lead to a search for a diaphragmatic cause which is not always the result of Reanimation Neuropathy but may also indicate a neuralgic amyotrophy. It is the fourth case of neuralgic amyotrophy following COVID-19. This brings the medical community to consider the risk of diaphragm paralysis apart from critical illness polyneuropathy. Respiratory muscle evaluation and diaphragmatic ultrasound should be considered in case of persistent dyspnoea.

Identifiants

pubmed: 34325956
pii: S0761-8425(21)00306-5
doi: 10.1016/j.rmr.2021.06.004
pmc: PMC8233958
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

853-858

Informations de copyright

Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

T Viatgé (T)

Service de pneumologie, hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France. Electronic address: viatge.t@chu-toulouse.fr.

E Noel-Savina (E)

Service de pneumologie, hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France.

G Prévot (G)

Service de pneumologie, hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France.

G Faviez (G)

Service de pneumologie, hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France.

G Plat (G)

Service de pneumologie, hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France.

X De Boissezon (X)

Service de médecine physique et de réadaptation, hôpital Rangueil, CHU de Toulouse, 31059 Toulouse cedex 9, France.

P Cintas (P)

Service de neurologie, hôpital Purpan, CHU de Toulouse, 31059 Toulouse cedex 9, France.

A Didier (A)

Service de pneumologie, hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH